Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06623097 · ClinicalTrials.gov registry record · NA
Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study
A NA study of Cancer Survivorship, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 1,528
- Enrollment target
- 2
- Study locations
NCT06623097: Recruiting NA study of Cancer Survivorship, sponsored by Dana-Farber Cancer Institute.
NCT06623097 is a NA study of Cancer Survivorship that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 1,528 participants, above the 122-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (1152% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06623097, a NA study of Cancer Survivorship, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,528 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study will compare the impact of virtually supervised and unsupervised home-based exercise and diet programs on cognitive and physical function among cancer survivors and support persons. This study will involve a 6-month home-based virtually supervised or unsupervised exercise and diet intervention. The names of the study interventions involved in this study are: * Virtually supervised exercise and healthy diet care * Unsupervised exercise and healthy diet care
Primary Outcome
The Montreal Cognitive Assessment (MOCA) will also be used to assess global cognition.
Conditions Studied
Interventions
- BEHAVIORAL Supervised Exercise and Diet Program
- BEHAVIORAL Unsupervised Exercise and Diet Program
Study Locations (2)
Florida
- University of Miami Sylvester Comprehensive Cancer Center - Miami
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,528 participants |
| Start Date | 2025-07-23 |
| Est. Completion | 2030-04-30 |
| Phase | NA |
What NCT06623097 shows while recruiting
NCT06623097 is an interventional study that assigns participants to a tested intervention. Its 1,528 participants enrollment target places it among the larger protocols in the corpus, above the 122-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (1152% higher).
The record links to 1 condition, with Cancer Survivorship appearing as the primary indexed condition, and to 2 interventions - of which Supervised Exercise and Diet Program is the first listed.
NCT06623097 reports a single indexed study location in Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06623097 about?
NCT06623097 is a clinical study titled "Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study". This research study will compare the impact of virtually supervised and unsupervised home-based exercise and diet programs on cognitive and physical function among cancer survivors and support persons. This study will involve a 6-month home-based virtually supervised or unsupervised exercise and die...
What is the current status of trial NCT06623097?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,528 participants. The study started on 2025-07-23. Estimated completion is 2030-04-30.
What conditions does trial NCT06623097 study?
This clinical trial studies the following conditions: Cancer Survivorship.
What interventions are being tested in trial NCT06623097?
The interventions under investigation include: Supervised Exercise and Diet Program (BEHAVIORAL), Unsupervised Exercise and Diet Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06623097?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06623097 being conducted?
This trial has 2 study locations across Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Survivorship
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06623097's enrollment target sits among peer trials
1,528 1st of 11 higher than 11 of 11 other Cancer Survivorship trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Survivorship trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
-
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
RECRUITING · NA
-
mHealth Intervention for Pain Self Management
RECRUITING · NA
-
Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
-
Cooperative Extension and Cancer Survivorship
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06393374 · 1,530 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- NCT07114510 · 1,530 participants · NA
Optimal Ventilation for Cardiac Arrest
- NCT06257082 · 1,526 participants · NA
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
- NCT06876714 · 1,524 participants · Phase 3
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI